
Philippe
Archinard is a consultant and business angel. He also chairs Fabentech and serves on the Board of Directors of bioMérieux and of several start-ups in oncology.
With strong experience in developing innovative biotechnology companies and
leading strategic partnerships, Philippe previously served as Deputy Chief Executive Officer in charge of Innovation and Partnerships at Institut Mérieux, after having led Transgene as Chairman and CEO.
He is a chemical engineer, holds a PhD
in biochemistry from the University of Lyon, and graduated from a management program at Harvard Business School.